Trials / Completed
CompletedNCT03806712
Comprehensive Study of Social Representation of Platelet Transfusion in Patients Followed for Advanced Hematological Malignancies (R-PLQ)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 45 (actual)
- Sponsor
- Centre Hospitalier Universitaire de Besancon · Academic / Other
- Sex
- All
- Age
- 18 Years – 100 Years
- Healthy volunteers
- Not accepted
Summary
Limited data is available for end of life care in hematologic malignancies, moreover with thrombocytopenic patients. Thrombopenia is a frequent complication, specific of bone marrow involvement in those diseases or its treatments. Yet, a few studies was interested in, whereas platelet transfusion is the only treatment indicated. As it represent a scarce, limited resource, the ethical principles are in conflict in this setting and there's a lack of recommendation. The final decision is take by the clinician and his patient, but no study exist in representation of the two parts. We provide a qualitative study to understand what this decision is made of.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | multi method questionary (developped by De Rosa, in 1995 and 2014) | questions from an association network according to the subject and the grounded theorise (Glasser and Strauss) |
Timeline
- Start date
- 2019-04-01
- Primary completion
- 2019-06-01
- Completion
- 2019-07-22
- First posted
- 2019-01-16
- Last updated
- 2019-07-25
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT03806712. Inclusion in this directory is not an endorsement.